GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » PS Ratio

CME Group (CME Group) PS Ratio

: 13.36 (As of Today)
View and export this data going back to 2002. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, CME Group's share price is $207.28. CME Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $15.52. Hence, CME Group's PS Ratio for today is 13.36.

Good Sign:

CME Group Inc stock PS Ratio (=13.29) is close to 3-year low of 12.18

The historical rank and industry rank for CME Group's PS Ratio or its related term are showing as below:

CME' s PS Ratio Range Over the Past 10 Years
Min: 7.06   Med: 12.74   Max: 19.1
Current: 13.31

During the past 13 years, CME Group's highest PS Ratio was 19.10. The lowest was 7.06. And the median was 12.74.

CME's PS Ratio is ranked worse than
81.07% of 750 companies
in the Capital Markets industry
Industry Median: 4.055 vs CME: 13.31

CME Group's Revenue per Sharefor the three months ended in Dec. 2023 was $4.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $15.52.

Good Sign:

CME Group Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of CME Group was 11.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.70% per year.

During the past 13 years, CME Group's highest 3-Year average Revenue per Share Growth Rate was 26.10% per year. The lowest was -2.00% per year. And the median was 6.50% per year.

Back to Basics: PS Ratio


CME Group PS Ratio Historical Data

The historical data trend for CME Group's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.77 13.37 17.49 12.03 13.57

CME Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.03 13.45 12.71 13.46 13.57

Competitive Comparison

For the Financial Data & Stock Exchanges subindustry, CME Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CME Group PS Ratio Distribution

For the Capital Markets industry and Financial Services sector, CME Group's PS Ratio distribution charts can be found below:

* The bar in red indicates where CME Group's PS Ratio falls into.



CME Group PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

CME Group's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=207.28/15.518
=13.36

CME Group's Share Price of today is $207.28.
CME Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.52.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


CME Group  (NAS:CME) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


CME Group PS Ratio Related Terms

Thank you for viewing the detailed overview of CME Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CME Group (CME Group) Business Description

Address
20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Executives
William R Shepard director 20 S. WACKER DR, CHICAGO IL 60606
Bryan T Durkin officer: MD & COO 20 S. WACKER DRIVE, CHICAGO IL 60606
Derek Sammann officer: Managing Dir Financial Product 20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Suzanne Sprague officer: Sr MD Global Head of Clearing 20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Timothy Francis Mccourt officer: Sr MD Global Head Equity & FX 20 S WACKER DRIVE, CHICAGO IL 60606
Elizabeth A Cook director 20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman director 20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy director 20 S. WACKER DR, CHICAGO IL 60606
Julie Holzrichter officer: MD Operations 20 S. WACKER DRIVE, CHICAGO IL 60606
Timothy S. Bitsberger director 20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler officer: Chief Commercial Officer 20 S. WACKER DR., CHICAGO IL 60606
Daniel R Glickman director 20 S. WACKER DR, CHICAGO IL 60606
Hilda Harris Piell officer: MD, Organizational Development 20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho officer: President, CME Clearing 20 S. WACKER DR., CHICAGO IL 60606

CME Group (CME Group) Headlines